Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-02-14, with 84 holding rows worth $255,659,000.

Accession
0001521536-14-000045
Filed
2014-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2013

A holdings report, 84 entries on the cover page, a total value of $255,659,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $255,659,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REGENERON PHARMACEUTICALS COM75886F107Stock37,000$10,184,000thousands by filing date
CELGENE CORP151020104COM49,000$8,279,000thousands by filing date
Gilead Sciences,Inc.375558103COM109,000$8,191,000thousands by filing date
CVS Health Corporation126650100COM107,000$7,658,000thousands by filing date
BIOGEN INC COM09062X103Stock27,000$7,553,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM240,000$7,286,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM100,000$7,027,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM50,000$6,653,000thousands by filing date
PHARMACYCLICS INC716933106COM60,000$6,347,000thousands by filing date
ALKERMES PLCG01767105SHS145,000$5,896,000thousands by filing date
AEGERION PHARMACEUTICALS INC00767E102COM75,000$5,322,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK400,000$5,180,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM55,000$4,947,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM700,000$4,774,000thousands by filing date
THERAVANCE INC88338T104COMMON STOCK132,000$4,706,000thousands by filing date
Johnson & Johnson478160104COM50,000$4,580,000thousands by filing datecall
EXPRESS SCRIPTS HLDG CO30219G108COM65,000$4,566,000thousands by filing date
INCYTE CORP COM45337C102Stock85,000$4,304,000thousands by filing date
MEDTRONIC INC585055106COM75,000$4,304,000thousands by filing date
Merck & Co.,Inc.58933Y105COM85,000$4,254,000thousands by filing date
Bristol-Myers Squibb Company110122108COM72,000$3,827,000thousands by filing date
UnitedHealth Group Inc91324P102COM44,000$3,313,000thousands by filing date
Boston Scientific Corporation101137107COM275,000$3,306,000thousands by filing date
FOREST LABS INC345838106COM55,000$3,302,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM8,000$3,073,000thousands by filing date
COVIDIEN PLCG2554F113SHS45,000$3,065,000thousands by filing date
WELLPOINT INC94973V107COM32,000$2,956,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM210,000$2,900,000thousands by filing date
CENCORA INC COM03073E105Stock40,000$2,812,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock30,000$2,796,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM25,000$2,784,000thousands by filing date
INSULET CORP COM45784P101Stock75,000$2,783,000thousands by filing date
ALLERGAN INC018490102COM25,000$2,777,000thousands by filing date
BECTON DICKINSON & CO075887109COM25,000$2,762,000thousands by filing date
Johnson & Johnson478160104COM30,000$2,748,000thousands by filing date
THORATEC CORP885175307COM75,000$2,745,000thousands by filing date
AETNA INC NEW00817Y108COM40,000$2,744,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158102COM1,400,000$2,744,000thousands by filing date
DEXCOM INC COM252131107Stock77,000$2,727,000thousands by filing date
VARIAN MED SYS INC92220P105COM35,000$2,719,000thousands by filing date
HCA Healthcare Inc40412C101COM55,000$2,624,000thousands by filing date
CYBERONICS23251P102COMMON STOCK40,000$2,620,000thousands by filing date
PAREXEL INTL CORP699462107COM58,000$2,620,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR65,000$2,605,000thousands by filing date
BAXTER INTL INC071813109COM37,000$2,573,000thousands by filing date
ST JUDE MED INC790849103COM40,000$2,478,000thousands by filing date
CIGNA CORPORATION125509109COM27,000$2,362,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock40,000$2,288,000thousands by filing date
OMNICARE INC681904108COM37,000$2,233,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM110,000$2,224,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM90,000$2,179,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM190,000$2,157,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW45,000$2,147,000thousands by filing date
EXELIXIS INC COM30161Q104Stock350,000$2,146,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM85,000$2,124,000thousands by filing date
MCKESSON CORP COM58155Q103Stock13,000$2,098,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock35,000$2,063,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW38,000$1,999,000thousands by filing date
REVVITY INC714046109COM45,000$1,855,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock360,000$1,804,000thousands by filing date
Eli Lilly and Company532457108COM35,000$1,785,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK45,000$1,767,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK85,000$1,763,000thousands by filing date
BARD C R INC067383109COM13,000$1,741,000thousands by filing date
ABIOMED INC003654100COM65,000$1,738,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM225,000$1,697,000thousands by filing date
MYRIAD GENETICS INC62855J104COM80,759$1,694,000thousands by filing date
ACTAVIS PLCG0083B108SHS10,000$1,680,000thousands by filing date
HOLOGIC INC436440101COM72,000$1,609,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK100,000$1,467,000thousands by filing date
ENDOLOGIX INC29266S106COM81,027$1,413,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK250,000$1,408,000thousands by filing date
CEPHEID15670R107COM30,000$1,402,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock30,000$1,264,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW250,000$1,168,000thousands by filing date
TROVAGENE INC897238309COM200,000$1,148,000thousands by filing date
VOLCANO CORPORATION928645100COM45,000$983,000thousands by filing date
NEWLINK GENETICS CORP651511107COM40,000$880,000thousands by filing date
VERADIGM INC01988P108COMMON STOCK55,000$850,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872104COM300,000$540,000thousands by filing date
Synta Pharmaceuticals Corp.87162T206COM100,000$524,000thousands by filing date
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM25,000$412,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares119,297$366,000thousands by filing date
ENDOCYTE INC29269A102COM25,000$267,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001521536-14-000045this filing2014-02-14acceptance time not in the bulk data set